Overexpression of Gsα in NG108-15, neuroblastoma X glioma cells: effects on receptor regulation of the stimulatory adenylyl cyclase cascade  by Mullaney, Ian et al.
FEBS 17814 FEBS Letters 397 (1996) 325-330 
Overexpression of G,a in NG108-15, neuroblastoma x glioma cells : 
effects on receptor regulation of the stimulatory adenylyl cyclase cascade 
Ian Mullaney, I. Craig Carr, Graeme Milligan* 
Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, Davidson Building, 
University of Glasgow, Glasgow G12 8QQ, UK 
Received 4 October 1996 
Abstract Neuroblastoma X glioma hybrid, NG108-15 cells were 
stably transfected with an epitope tagged variant of G,a (HA- 
G,@. The introduced HA-G,a was able to interact with the IP 
prostanoid receptor and was able to stimulate adenylyl cyclase 
activity as measured by an enhanced capacity of membrane 
extracts to reconstitute NaF-dependent adenylyl cyclase activity 
to membranes of S49 lymphoma cyc- cells. Despite this, neither 
the maximal stimulation nor the potency of agonist llgands at the 
IP prostanoid, A2 adenosine or secretin receptors was altered 
substantially compared to the parental cells although the basal 
adenylyl cyclase activity was increased. These data indicate that 
cellular levels of G,a do not limit signal transduction capacity in 
NGlOS-15 cells, whereas enhanced expression of adenylyl 
cyclase allows greater maximal CAMP generation following 
receptor activation (MacEwan, D.J., Kim, G.D. and Milligan, 
G. (1996) Biochem. J. 318, 1033-1039). 
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1. Introduction 
Relatively little is known about the absolute levels of ex- 
pression of the protein components of signal transduction 
cascades in different cell types and how alterations in levels 
of these proteins may alter the effectiveness of hormone and 
neurotransmitter function [l]. In an effort to address these 
questions we have been using neuroblastoma X glioma, 
NG108-15, hybrid cells and examining the stimulatory regula- 
tion of adenylyl cyclase. These cells express approximately 10” 
copies per cell of the IP prostanoid receptor, lo6 copies per 
cell of the a subunit of the G protein G, and some 2 X lo4 
copies per cell of adenylyl cyclase [2]. We have previously 
stably transfected these cells and isolated clones expressing 
varying levels of the Pz-adrenoceptor and shown that the ade- 
nylyl cyclase activity can be maximally stimulated by isopre- 
naline in cells expressing high levels of the receptor [3,4]. Even 
in clones expressing relatively low levels of the receptor, maxi- 
mally effective concentrations of isoprenaline caused the same 
maximal stimulation of adenylyl cyclase activity but the po- 
tency of the agonist was reduced [3,4]. These observations are 
consistent with the cells expressing high levels of the receptor 
displaying a large receptor reserve [3,4]. By contrast, increas- 
ing total cellular levels of adenylyl cyclase by stable transfec- 
tion of type II adenylyl cyclase into these cells resulted in a 
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markedly greater maximal activation of adenylyl cyclase with- 
out a change in the potency of the agonist ligands [5]. 
In the present study we overexpress the third component of 
the stimulatory adenylyl cyclase cascade (G,a) in NG108-15 
cells and then assess basal and receptor regulation of adenylyl 
cyclase activity. 
2. Materials and methods 
2.1. Materials 
All reagents for tissue culture were purchased from Life Technolo- 
gies, Paisley, Strathclyde, UK. a[32P]ATP and t3H]cAMP were ob- 
tained from Amersham International. Iloprost was a kind gift of 
Schering Health Care, Burgess Hill, Sussex, UK. Other receptor lig- 
ands were purchased from the Sigma Chemical Company (Poole, 
UK). All other chemicals were bought from Sigma or British Drug 
Houses (BDH) and were of the highest purity available. The cDNA 
for HA-G,a in pcDNA1 was a kind gift from Drs M.J. Levis and 
H.R. Bourne, University of California at San Francisco, CA, USA. 
2.2. Methods 
2.2.1. Generation and isolation of clones of NG108-I5 cell variants 
expressing HA-G,a(L). NG108-15 cells were stably co-transfected 
with plasmid pcDNA1 (10 pg) containing a cDNA (HA-G,c() encod- 
ing the long isoform of G,a in which a section of the haemagglutinin 
epitope (VPDYA) was constructed between amino acid residues 7682 
[6] and plasmid pBABE hygro (1 pg) which confers resistance to 
hygromycin B. Clones which were resistant to hygromycin B (200 
pg/ml) were selected and expanded. Clone BSTl5 [7] was selected 
for analysis in this study (see Fig. 1). 
2.2.2. Cell culture. NGl08-15 and clone BSTIS cells were grown 
in Dulbecco’s modified Eagle’s medium (DMEM) which was supple- 
mented to 5% (v/v) with fetal bovine serum. This medium was further 
supplemented with hypoxanthine, aminopterin, thymidine, 100 U/ml 
of penicillin and 100 @ml streptomycin. Clone BSTl5 was further- 
more maintained in medium containing hygromycin B (200 @ml). 
S49 lymphoma cyc- cells were grown in DMEM containing 10% 
heat-inactivated horse serum and maintained between 5 X lo5 and 
2 X lo6 cells/ml. 
2.2.3. Membrane preparation. Cells were harvested, washed twice 
in phosphate buffered saline and pelleted by centrifugation at 500 xg 
for 10 min on a Beckman TJ-6 benchtop centrifuge. Membranes were 
prepared by homogenizing the cell pellet with 20 strokes of a Teflon/ 
glass homogenizer in 10 mM Tris-HCl, 0.1 mM EDTA pH 7.5 (buffer 
A). The resultant supernatant was centrifuged at 5OOXg for 10 min in 
a Beckman L5-50B centrifuge with a Ti50 rotor, to remove unbroken 
cells and nuclei. The supernatant was further centrifuged at 48 000 Xg 
for 10 min. The pellet from this centrifugation was resuspended in 
buffer A and recentrifuged at 48 000 Xg for IO min. The resultant 
pellet was resuspended in an appropriate volume of buffer A, ali- 
quoted and stored at -80°C until use. 
2.2.4. Immunoblotting. Membranes were resolved by SDS-PAGE 
(10% (w/v) acrylamide) and subsequently immunoblotted with a range 
of antisera. Antiserum CS, initially characterised by Milligan and 
Unson [8] was raised in a New Zealand White rabbit after immuniza- 
tion with a glutaraldehyde conjugate of keyhole limpet haemocyanin 
and a synthetic peptide, RMHLRQYELL, which corresponds to the 
C-terminal decapeptide common to all isoforms of G,a. This sequence 
is also preserved in the HA epitope-tagged variant of G,a. Monoclon- 
al antibody 12CA5 which identifies a nonapeptide sequence 
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(YPYDVPDYA) derived from the haemagglutinin protein of human 
influenza virus was a gift from Dr M.J. Stark, Department of Bio- 
chemistry, University of Dundee. Immunoblots were quantitated 
using a Bio-Rad GS-670 Imaging Densitometer linked to an Apple 
Macintosh Quadra 800 microcomputer. 
2.2.5. Immunoprecipitation of G-proteins. To the 200 ul of SDS- 
denatured cell suspension was added 800 pl of solubilization buffer 
(1% (w/v) Triton X-100, 10 mM EDTA, 100 mM NaHsPOh, 10 mM 
NaF, 100 uM NasVOd, 50 mM HEPES pH 7.2), and 100 ~1 of Pan- 
sorbin (Calbiochem). Samples were incubated at 4°C with continuous 
rotation for I-2 h for non-specific preclearing. Following centrifuga- 
tion of the samples (16OOOXg, 2 min, 4°C) the. supernatant was col- 
lected and subjected to immunoprecipitation by addition of 100 ul of 
protein A-agarose along with 10 pl of antiserum CS or 1 11 of anti- 
body 12CAS and incubated at 4°C for 4 h. Immune complexes were 
then recovered by centrifugation (16 000 x g, 30 s at 4°C) and washed 
by resuspension-centrifugation three times each with 1 ml of wash 
buffer (1% (w/v) Triton X-100, 100 mM NaCl, 100 mM NaF, 50 
mM NaH2P04, 50 mM HEPES, pH 7.2, 0.5% (w/v) SDS). The final 
protein A-agarose pellet was resuspended in Laemmli sample buffer, 
heated at 100°C for 5 min and electrophoresed by SDS/PAGE (10% 
(w/v) acrylamide). Following resolution of the proteins, the gel was 
stained with Coomassie blue and then dried. The dried gels were 
exposed either to photographic film or to phosphor storage screen 
autoradiography according to the manufacturer’s instructions using 
a Fujix Bio-imaging Analyser linked to an Apple Macintosh Quadra 
650 personal computer. 
2.2.6. Reverse transcriptaselpolymerase chain reaction. The reverse 
transcriptase/PCR procedure was essentially as described by Steel and 
Buckley 191. Total RNA was extracted using RNAzol B (Biogenesis). 
Purity and quantification of RNA were assessed by spectrophoto- 
metric A260/A280 ratios. Samules of 5-10 ug RNA (20 ul) were 
denatured by incubation at 65°C for 10 min f&owed by chilling on 
ice and reverse transcribed in 33 ~1 of reaction mixture using first 
strand cDNA synthesis kit (Pharmacia LKB Biotechnology) as de- 
tailed by the manufacturer. Incubation was carried out at 37°C for 
1 h. The reactions were terminated by heating samples at 95°C for 
5 min followed by transfer to ice. 
PCR reactions were carried out using the following primers: 
G&-sense, 5’-CCACCTGAATTCTATGAGCATGCC-3’ 
HA-G,cr-sense, 5’-GAGGACGTGCCGGATTACGCG-3’ 
G,a-antisense, 5’-GCGTGGGTCCTCTCCGGGCTCGGG-3’ 
Amplifications were performed in 50 ul of buffer containing 25 pmol 
of primers and 2.5 U of Taq polymerase (Promega) using a HYBAID 
Omnigene temperature cycler. Amplifications were carried out as fol- 
lows: 95W5 min, 6O”C/30 s, 72”C/l min (1 cycle); 95”C/30 s, 6O”C/30 
s, 72”C/l min (30 cycles) 95”C/30 s, 6O”C/30 s, 72”C/5 min (1 cycle). 
Reaction products were then separated by 1.5-l .75% agarose gel elec- 
trophoresis. In each case the size of the generated product was that 
anticipated from the selected primers. 
2.2.7. Adenylyl cyclase assays. Adenylyl cyclase assays on mem- 
branes of NG108-15 cells and of clone BSTl5 were performed as 
described by Milligan et al. [IO]. Reconstitution of NaF-stimulated 
adenylyl cyclase activity to membranes of S49 lymphoma cycc cells, 
which do not express G,a, with sodium cholate extracts of NG108-15 
and BSTl5 membranes was performed as described by McKenzie and 
Milligan [l 11. 
tide conserved between all splice variants of G,a [S]. All of the 
clones tested endogenously expressed good levels of the long 
(45 kDa) splice variant of G,a and a number of them also 
expressed a second CS immunoreactive polypeptide which mi- 
grated somewhat more slowly in SDS-PAGE (Fig. 1A). Clone 
BSTlS was used in this study as it expressed this construct to 
the highest level and in the passages of cells used for this 
study membrane levels of HA-G,a were some 60% of the 
levels of the endogenously expressed wild type long isoform 
of G,a (Fig. 1). Confirmation of the identity of this polypep- 
tide as HA-G,a was obtained by a number of distinct strate- 
gies. RNA isolated from both parental NG108-15 cells and 
clone BSTl5 was reversed transcribed and polymerase chain 
reaction then performed using primer pairs designed to am- 
plify a fragment from authentic G,a (Fig. lB, panel A) or 
from HA-G,a (Fig. lB, panel B). A product corresponding to 
wild type G,cr was obtained from both parental NG108-15 
cells and from clone BSTl5 whereas a product derived from 
HA-G,a was obtained only from clone BST15. Immunopre- 
cipitation of membranes of either NG108-15 cells or of clone 
BSTl5 cells with antibody 12CA5 (which identifies the HA- 
epitope) resulted in recovery of a CS immunoreactive poly- 
peptide of the expected molecular mass only from the BSTl5 
cell membranes (Fig. 1C) (although the efficiency of immuno- 
precipitation of HA-G,a with antibody 12CA5 was poor) and 
cholera toxin-catalysed [s’P]ADP-ribosylation of membranes 
of NG108-15 and BST15 cells allowed immunoprecipitation 
of a single 45 kDa polypeptide (as well as a considerably 
lower amount of a 42 kDa polypeptide which is the short slice 
variant of G,a) from NG108-15 cell membranes with antiser- 
um CS (Fig. lD, lanes 34) but a doublet of 45 kDa poly- 
peptides (as well as the 42 kDa polypeptide) from clone 
BSTl5 cell membranes (Fig. lD, lanes 9910). Immunoprecipi- 
tation of the membranes with antibody 12CA5 following cho- 
lera toxin-catalysed [32P]ADP-ribosylation failed to immuno- 
precipitate a radiolabelled polypeptide from membranes of 
NG108-15 cells (Fig. lD, lanes 5-6) but isolated a single 45 
kDa polypeptide from BSTl5 cell membranes (Fig. lD, lanes 
11-12) which corresponded to the more slowly migrating 
polypeptide immunoprecipitated with antiserum CS. 
We have previously concluded that the IP prostanoid re- 
ceptor can interact with both HA-G,a and G,a in clone 
Table 1 
Reconstitution of adenylyl cyclase activity to membranes of S49 
cvc cells bv cholate extracts of NG108-15 and BSTl5 cells: re- 
quirement fo; NaF 
Addition Cholate extract 
NGl08-15 BSTl5 
3. Results Adenylyl cyclase activity 
(pmol/min/mg cycc membrane) 
NG108-15 cells were transfected stably with a combination 
of plasmid pcDNA1 containing a cDNA (HA-G,a) encoding 
the long isoform of G,a in which a section of the primary 
sequence was modified to encode part of the haemagglutinin 
epitope and plasmid pBABE hygro which confers resistance to 
hygromycin B [7]. Clones displaying resistance to hygromycin 
(200 ug/ml) were expanded. Membranes derived from these 
clones were resolved by SDS-PAGE and immunoblotted 
with antiserum CS, which identifies the C-terminal decapep- 
None 7.6 f 0.4 8.0f0.7 
NaCl (10 mM) 10.3 f 0.4 9.7 f 0.7 
NaF (10 mM) 45.2+ 1.8 73.4 + 3.5 
The adenylyl cyclase activity of 10 ug of S49 cycc cell membranes was 
measured for 1 h at 30°C in the presence of sodium cholate (1% (w/v), 
1 h, 4°C) extract derived from 10 ug of membranes of either NG108 
15 or BSTlS cells. The assays were further supplemented with either 
NaCl or NaF (10 mM). Data represent meansfS.E.M. of triplicate 
assays from an experiment which was representative of three per- 
formed. 
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Fig. I. Overexpression of G,a in NGlO%15 derived clones following transfection with an HA-epitope tagged variant of G,a. A: Immunoblot- 
ting for G,a detects an additional form following stable transfection of NG108-15 cells with HA-G,a. Membranes (25 ug) derived from a series 
of clones displaying resistance to hygromycin B, derived following co-transfection of NG108-15 cells with plasmids encoding each of HA-G&a 
and resistance to hygromycin B were resolved by SDS-PAGE (10% (w/v) acrylamide), transferred to nitrocellulose and immunoblotted using 
antiserum CS (1:500 dilution) as primary reagent. Clone (BST)15 displayed the highest levels of expression of what is putatively HA-G,a. 
B: Clone BSTl5 but not NGlO%15 cells expresses mRNA corresponding to HA-G,a. Reverse transcriptase-PCR was performed on RNA iso- 
lated from either NG108-15 (1) or clone BSTl5 (2) cells using primers (see Section 2.2) designed to amplify wild type G,a (A) or HA-G,a (B). 
Positive controls for the PCR reactions using relevant cDNA species are also shown (3). C: Immunoprecipitation of HA-G-a from membranes 
of clone BSTl5 but not NG108-15 cells with an HA-epitope directed antiserum. Membranes (25 ug, left hand panel, 200 ug, right hand panel) 
from BST15 (1) and NG108-15 (2) cells were immunoblotted with antiserum CS (left hand panel) or immunoprecipitated with antibody 12CA5 
prior to immunoblotting with antiserum CS (right hand panel). D: Both G,a and HA-G,a act as substrates for cholera toxin-catalysed 
[“‘PIADP-ribosylation. Membranes (100 ug) from NG108-15 (l-6) and BST15 (7712) cells were subjected to cholera toxin-cataiysed [32P]ADP- 
ribosylation. These were subsequently not treated (1, 7) or immunoprecipitated with normal rabbit serum (2, 8), antiserum CS (3, 4. 9, 10) or 
antibody 12CA5 (5, 6, 11, 12). The samples were then resolved on SDS-PAGE and autoradiographed. 
BSTl5 cells as assessed by the ability of sustained treatment 
of the cells with the IP prostanoid receptor agonist iloprost to 
cause equivalent downregulation of both forms of the G pro- 
tein [7]. We investigated whether membranes of clone BST 15 
expressed higher levels of functionally active G,a than mem- 
branes of NG108-15 cells. As anticipated, membranes of S49 
lymphoma cycc cells did not express an immunodetectable 
level of G,CX (data not shown) and addition of either NaF 
or NaCl (10 mM) failed to cause stimulation of adenylyl cy- 
clase activity (Table 1). Extraction of membranes of NG108- 
15 cells with sodium cholate (1% (w/v), 1 h, 4’C) followed by 
reconstitution of the soluble extract with S49 lymphoma cyc- 
membranes allowed a marked NaF-stimulation of adenylyl 
cyclase activity. This was specific for NaF as NaCl was with- 
out significant effect (Table 1). Equivalent solubilisation and 
reconstitution of G,a from membranes from clone BST15 
resulted in an approximately 70% greater NaF stimulation 
of S49 lymphoma cyc- membrane adenylyl cyclase activity 
than achieved with the extract of NG108-15 cells (Table 1). 
Reconstitution of cyc- membranes with varying amounts of 
NG108-15 and BST15 cell membrane sodium cholate extracts 
resulted in a linear increase in NaF-induced adenylyl cyclase 
activity over the range of amounts examined (Fig. 2) with 
greater activity observed for the BSTl5 cell membrane ex- 
tracts at all levels used. 
The adenylyl cyclase activity of membranes of NG108-15 
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cells and clone BSTl5 and its regulation by agonist ligands 
was compared. There was a significant increase in basal ade- 
nylyl cyclase activity in membranes of clone BST15 compared 
to NG108-15 cells (1.33 kO.07 fold, mean? S.E.M., n= 8). 
Iloprost caused a concentration-dependent stimulation of ade- 
nylyl cyclase activity in membranes of both cell lines. The 
ECss for iloprost (4.8 + 0.6 X 10e8 M in NG108-15 cells and 
5.2f2.0~10~~ M in BSTlS cells (meansfS.E.M., n=3)) 
(Fig. 3) was not different between the two clones and the 
maximal level of adenylyl cyclase activity which could be 
achieved was similar (Fig. 3). Agonists at the Aa adenosine 
(5’-N-ethylcarboxamidoadenosine (NECA), NG108-15 
ECss = 9.1 + 2.0x 1O-7 M, BSTlS ECss = 6.0 f 2.2 x 1O-7 M) 
and secretin (secretin, NG108-15 EC50 = 5.7 + 2.6 X lo-’ M, 
BSTlS EC50 = 8.4 f 3.8 x 10es M, means f S.E.M., n = 3 in 
each case) receptors also displayed no differences in their con- 
centration-dependence for stimulation of adenylyl cyclase ac- 
tivity (Fig. 4). However, neither of these ligands was capable of 
producing as large a maximal stimulation of adenylyl cyclase 
activity as iloprost in either cell line (NECA = 36.6 f 3.3%, 
meanfS.E.M., n=3; secretin=26.2+6.4%, mean+S.E.M., 
n=4). 
4. Discussion 
Transgenic alterations in the protein components of cell 
signalling cascades can now be achieved in mice. Indeed, over- 
expression of both the pi [12] and Bs [13]-adrenoceptors in a 
cardiac-specific manner has been reported with the aim of 
examining the relative role of these two catecholamine recep- 
tors in cardiac function and to allow analysis of whether the 
cardiac insufficiency associated with the failing heart [14] 
might be alleviated by gene therapy approaches based on 
alteration in adrenergic stimulation of adenylyl cyclase. 
Although these studies have been both technically challenging 
70 1 /m 
O/ 
0 2 4 6 8 10 12 
Sodium cholate extract (Bg) 
Fig. 2. Membranes of BSTl5 cells contain greater levels of S49 lym- 
phoma cyc- reconstitution activity than NG108-15 cells. Adenylyl 
cyclase assays were performed on S49 lymphoma cyc- membranes 
(10 pg) in the presence of 10 mM NaF as in Table 1 except that so- 
dium cholate extracts corresponding to varying amounts of mem- 
brane protein derived from NG108-15 (filled symbols) and BSTl5 
(open symbols) cells were reconstituted with the cyc- membranes. 
Adenylyl cyclase activity measured in the absence of addition of the 
sodium cholate extracts was not stimulated by the presence of NaF 
(see Table 1) and was subtracted from all the other values. Two 
further experiments produced similar results. 
350 1 
50 I,; I I I I I i I I 
0 lo-‘O 1oa8 10 B 1 0’ 4 
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Fig. 3. Iloprost stimulates adenylyl cyclase activity equally in mem- 
branes of NG108-15 and BSTl5 cells. Basal adenylyl cyclase activity 
and its regulation by varying concentrations of the IP prostanoid re- 
ceptor agonist iloprost was measured in membranes (10 ug) of 
NG108-15 (filled svmbols) or BST15 cells (onen svmbols). Data are 
presented as means + S.E.M. from quadruplicate assays from a rep- 
resentative experiment of three performed. 
and provided new insights into cardiac regulation, a more 
systematic approach to monitoring the levels of expression 
of the different protein components of signalling cascades 
and to understanding how modification of the levels of each 
may alter both the potency of agonists ligands and the max- 
imal potential output from the cascade need to be performed 
in parallel to provide insights into rational strategies to alter 
cell signalling efficiency. We are involved in this using neuro- 
blastomaxglioma hybrid, NG108-15, cells as a model test 
system [2-51. We have previously characterised the steady- 
state levels of expression of each of the IP prostanoid recep- 
tor, G,a and adenylyl cyclases, which comprise the primary 
response components of the stimulatory adenylyl cyclase cas- 
cade, in these cells [2] and demonstrated that increasing ex- 
pression of a G&-linked receptor (the Pa-adrenoceptor) re- 
sults in increasing potency [3,4] and intrinsic activity [4] of 
adrenergic ligands without altering the maximal possible out- 
put of the cascade (except at very low receptor densities [4]). 
By contrast, clones stably transfected to express higher levels 
of adenylyl cyclase responded with a greater maximal output 
following receptor occupancy without altering either the po- 
tency or efficacy of agonist ligands [5]. In the current study we 
have used a clone of these cells transfected to stably overex- 
press G,a and examined the functional effects of this altera- 
tion. 
The strategy adopted was to transfect the cells with an HA 
epitope-tagged variant of G,a to allow independent detection 
of expression of this polypeptide from the endogenously ex- 
pressed form of this G protein. Serendipitously, however, we 
observed that the HA-tagged form of G,a migrated more 
slowly in SDS-PAGE than the wild type protein and as 
such we could conveniently use an antiserum directed against 
a common region to probe the relative levels of expression of 
the two forms of G,a (Fig. 1). Although the degree of over- 
expression (as fold) of G,a in clone BSTl5 compared to 
NG108-15 cells may not seem particularly great, as noted 
above, this corresponds to the expression of approximately 
6 X lo5 extra copies per cell of G,o! in clone BSTl5 compared 
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Fig. 4. The regulation of adenylyl cyclase activity by the Aa adeno- 
sine and secretin receptors in similar in NG108-15 and BSTl5 cell 
membranes. Adenylyl cyclase activity and its regulation by varying 
concentrations of -NECk (A) or secretin (B) wasmeasured in meml 
branes of NG108-15 (filled svmbols) or BSTl5 (onen svmbols) cells. 
Data is presented a& over basal activity compared to that achieved 
by maximally effective concentrations of NECA (lop3 M) or secre- 
tin (10m5 M). Points represent meansfS.E.M. of quadruplicate as- 
says from representative experiments of three performed with each 
agonist. 
to NG108-15 cells. Despite this, the maximal capacity of the 
IP prostanoid receptor to cause stimulation of adenylyl cy- 
clase was not increased nor was the potency of the prostanoid 
agonist ilopost increased to any significant extent (Fig. 3). 
Very similar results to those of the IP prostanoid agonist 
were obtained with agonists at both the As adenosine and 
secretin receptors (Fig. 4) even though we have previously 
shown that the levels of expression of these two receptors is 
insufficient to allow maximal activation of the adenylyl cyclase 
cascade in NG108-15 cells [4,5]. Indeed, the only obvious 
alteration in adenylyl cyclase regulation in clone BSTlS com- 
pared to NG108-15 cells was an increase in the basal activity 
of this cascade. It was thus vital to validate that the relatively 
small effects observed was not a reflection that HA-G,a was 
incapable of causing stimulation of adenylyl cyclase activity. 
This was achieved by demonstrating that sodium cholate ex- 
tracts of BST15 cell membranes had approximately 70% 
greater capacity to allow reconstitution of NaF-stimulated 
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adenylyl cyclase activity to membranes of S49 lymphoma 
cyc- cells than equivalent extracts of NG108-15 cells (Fig. 2 
and Table 1). 
As such, transgenic strategies to increase levels of expres- 
sion of G,a do not seem a promising means to regulate signal 
transduction effectiveness. This may not be surprising in 
NG108-15 cells as we have noted previously that steady-state 
levels of G,a in these cells are substantially higher than levels 
of either the IP prostanoid receptor (some lo-fold) or adenylyl 
cyclase (some 70-fold) [2]. As such, further expression of G, 
might be anticipated to have a rather limited capacity to 
modify signal transduction efficiency. It will be of interest, 
in time, to try to reduce the cellular expression of G,a and 
then examine if this can reduce the effectiveness of adenylyl 
cyclase regulation. Virtually nothing is known of the levels of 
expression of signal transducing components in the majority 
of cells and tissues but it is interesting to note that G,u also 
appears to be expressed to considerable molar excess over 
adenylyl cyclase in cardiac myocytes [15] and thus it should 
not be surprising that overexpression of G,cx in the heart of 
mice also resulted in little functional modulation of the ade- 
nylyl cyclase cascade [16]. 
A further potential concern in studies such as this is to be 
able to demonstrate that the excess immunodetectable ex- 
pressed protein actually has a cellular distribution appropriate 
to its function and that it is actually accessed by agonist-oc- 
cupied receptors. We have previously demonstrated this for 
HA-G,a in clone BST15 by demonstrating that levels of both 
this form of the protein and the wild type, endogenous G,a 
are regulated equivalently by activation of the IP prostanoid 
receptor [7]. High level expression of G proteins in transient 
transfection studies can often be seen to result in greater max- 
imal effectiveness of co-transfected receptors. However, such 
studies tend to define potentials for receptor-G protein inter- 
actions and rarely attempt to provide quantitative details on 
levels of expression of the proteins of interest. The current 
study indicates that transgenic increases in levels of expression 
of G, are unlikely to provide large functional benefits unless 
the cell system under study can be shown to express endoge- 
nously only low levels of this G protein. 
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